The National Health Surveillance Agency (Anvisa) released the CoronaVac vaccine to be used in the immunization of children and adolescents aged 6 to 17 years, with a ban on its application in immunosuppressed patients. The vaccine is the second released for children and adolescents, succeeding Pfizer, approved in December 2021 for ages 5 to 11 […]
